Vir Biotechnology (VIR) Debt to Equity (2019 - 2025)
Historic Debt to Equity for Vir Biotechnology (VIR) over the last 5 years, with Q1 2025 value amounting to $0.02.
- Vir Biotechnology's Debt to Equity changed N/A to $0.02 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.02, marking a year-over-year change of. This contributed to the annual value of $0.01 for FY2024, which is N/A changed from last year.
- Vir Biotechnology's Debt to Equity amounted to $0.02 in Q1 2025.
- In the past 5 years, Vir Biotechnology's Debt to Equity ranged from a high of $0.08 in Q3 2021 and a low of $0.01 during Q4 2024
- Its 3-year average for Debt to Equity is $0.04, with a median of $0.04 in 2021.
- Within the past 5 years, the most significant YoY rise in Vir Biotechnology's Debt to Equity was 32623.92% (2021), while the steepest drop was 3323.61% (2021).
- Vir Biotechnology's Debt to Equity (Quarter) stood at $0.08 in 2021, then plummeted by 82.14% to $0.01 in 2024, then grew by 20.09% to $0.02 in 2025.
- Its Debt to Equity was $0.02 in Q1 2025, compared to $0.01 in Q4 2024 and $0.08 in Q3 2021.